In a clinical setting, since various degrees of cardiac inflammation and the progression of fibrosis may be present in a patient with heart disease, blood Gal-3 levels may reflect a sum of different stages of pathophysiological conditions [12]. The gene discussed is LGALS3; the disease is heart disorder.